SCHEMBL19508697

SCHEMBL19508697

CCc1cc(-c2ccc(N)cc2)nc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESRRB O95718 1/20 0.56
ESR1 P03372 1/20 0.56
ESRRA P11474 1/20 0.56
ESR2 Q92731 1/20 0.56
ACHE P22303 1/20 0.54
HPGD P15428 5/20 0.51
ALDH1A1 P00352 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 3/20 0.51
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
KDM4E B2RXH2 4/20 0.49
GMNN O75496 1/20 0.49
TP53 P04637 1/20 0.49
CYP3A4 P08684 1/20 0.49
PKM P14618 1/20 0.49
THPO P40225 1/20 0.49
BLM P54132 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13243228 0.89 ESRRB (0.59) ESRRBESR1ESRRAESR2ACHE
SCHEMBL13893908 0.86 ESR1 (0.58) ESRRBESR1ESRRAESR2ACHE
SCHEMBL20869723 0.84 ESR1 (0.78) ESRRBESR1ESRRAESR2HPGD
SCHEMBL30028973 0.81 ALDH1A1 (0.61) ACHEHPGDALDH1A1MEN1KMT2A
SCHEMBL10944758 0.81 ALDH1A1 (0.61) ACHEHPGDALDH1A1MEN1KMT2A
SCHEMBL17463551 0.79 ACACA (0.65) ACHEHPGDALDH1A1MEN1KMT2A
SCHEMBL12443218 0.78 ACHE (0.57) ACHEHPGDALDH1A1MEN1KMT2A
SCHEMBL483736 0.78 ACHE (0.57) ACHEHPGDALDH1A1MEN1KMT2A
SCHEMBL16921273 0.77 DHODH (0.80) HPGDALDH1A1KMT2ANPC1RAB9A
SCHEMBL7050208 0.76 BACE1 (0.61) ACHEHPGDALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017184547-A1 QUINOLINE COMPOUNDS AS MODULATORS OF RAGE ACTIVITY AND USES THEREOF NEW YORK UNIVERSITY (US) 2017-10-26 WO disclosed